Founded in 2025 by 14-year-old innovator Jaiwardhan Tyagi, Neurapex AI is building domain-specific artificial intelligence solutions to diagnose skin and neurological disorders. The startup secured ₹60 lakh in funding for 5% equity from Aman Gupta on Shark Tank India, valuing the venture at ₹12 crore.

With global studies indicating that over 30% of people suffer from skin and subcutaneous diseases—and specialist shortages impacting diagnostic accuracy—Neurapex AI aims to bridge early-stage healthcare gaps through structured AI-driven analysis.

The platform operates through DeepDerm, a live skin analysis engine trained on over 1.5 lakh medical image-text pairs, and AlzMind, a brain-scan classification system. Unlike general AI tools, it leverages clinical terminology to assess lesion types, severity, and clustering patterns, while also enabling condition-specific dermatologist matching.

Within a month of the televised funding announcement, Neurapex AI recorded 14,000 website visits and 2,300 sign-ups without paid marketing—signaling strong early market validation.